These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29407952)

  • 1. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
    Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
    Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.
    Zhao H; Jiang S; Ye Z; Zhu H; Hu B; Meng P; Hu Y; Zhang H; Wang K; Wang J; Tian Y
    Eur J Med Chem; 2021 Oct; 221():113567. PubMed ID: 34082224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
    Jia R; Zhang J; Ai W; Ding X; Desta S; Sun L; Sun Z; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2019 Sep; 178():64-80. PubMed ID: 31176096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
    Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
    Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.
    Jia R; Zhang J; Shi F; Bonomini A; Lucca C; Bertagnin C; Zhang J; Liu C; Jia H; Jiang Y; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2023 Apr; 252():115275. PubMed ID: 36931117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Evaluation of
    Hu Y; Chen B; Lei Z; Zhao H; Zhu H; Quan P; Tian Y
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of C5-NH
    Ju H; Murugan NA; Hou L; Li P; Guizzo L; Zhang Y; Bertagnin C; Kong X; Kang D; Jia R; Ma X; Du R; Poongavanam V; Loregian A; Huang B; Liu X; Zhan P
    J Med Chem; 2021 Dec; 64(24):17992-18009. PubMed ID: 34735766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
    Ye J; Yang X; Xu M; Chan PK; Ma C
    Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Boron-Containing
    Jia R; Zhang J; Zhang J; Bertagnin C; Bonomini A; Guizzo L; Gao Z; Ji X; Li Z; Liu C; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors.
    Hong BT; Chen CL; Fang JM; Tsai KC; Wang SY; Huang WI; Cheng YE; Wong CH
    Bioorg Med Chem; 2014 Dec; 22(23):6647-6654. PubMed ID: 25456388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel polyheterocyclic neuraminidase inhibitors with 1,3,4-oxadiazole thioetheramide as core backbone.
    Shang LL; Zhong ZJ; Cheng LP
    Eur J Med Chem; 2024 Apr; 269():116305. PubMed ID: 38518525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel thiophene derivatives as potent neuraminidase inhibitors.
    Zhong ZJ; Hu XT; Cheng LP; Zhang XY; Zhang Q; Zhang J
    Eur J Med Chem; 2021 Dec; 225():113762. PubMed ID: 34411893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.
    Wang Z; Cheng LP; Zhang XH; Pang W; Li L; Zhao JL
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5429-5435. PubMed ID: 29141777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.